IFNG and coronary artery disorder: Previous studies characterized the roles of miRNAs in cardiovascular diseases, e.g., miRNA-145 in venous thrombosis (12); miRNA-33, miR-133b, and miR-21 as biomarkers for early prediction of CAD (13, 14); and circulating lncRNAs IFNG-AS1 and CoroMarker as biomarkers for CAD (6, 15).